Maze Therapeutics (MAZE) - Volume dana dhuwit perusahaan

Maze Therapeutics Inc (MAZE) is developing a sophisticated cold-chain logistics system for the delivery of gene therapies. Revenues are based on the licensing of discoveries and the sale of targeted drugs to insurers. The innovative genomic platform enables the identification of precise targets for metabolic pathologies. Monitoring the cash balance on GURU.Markets, we note that the 0.40 level reflects the company's liquidity parameter.
Rincian metrik keuangan lan pasar Maze Therapeutics (MAZE)

This indicator reflects the actual balance of liquid assets, adjusted for short-term market volatility and one-off asset transactions. By analyzing operating cash flow, an investor assesses the financial stability of Maze Therapeutics Inc (MAZE), which is critical for funding costly genetic research and the development of personalized drugs for the therapy of renal pathologies and metabolic disorders.